TOXICITY OF IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER CELLS

被引：51

作者：

MIER, JW ^{[1
]}

ARONSON, FR ^{[1
]}

NUMEROF, RP ^{[1
]}

VACHINO, G ^{[1
]}

ATKINS, MB ^{[1
]}

机构：

[1] TUFTS UNIV,SCH MED,BOSTON,MA 02111

来源：

PATHOLOGY AND IMMUNOPATHOLOGY RESEARCH | 1988年 / 7卷 / 06期

关键词：

D O I：

10.1159/000157075

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：459 / 476

页数：18

共 67 条

[1] THE DEVELOPMENT OF ANTI-INTERLEUKIN-2 ANTIBODIES IN PATIENTS TREATED WITH RECOMBINANT HUMAN INTERLEUKIN-2 (IL-2) [J].

ALLEGRETTA, M ;

ATKINS, MB ;

DEMPSEY, RA ;

BRADLEY, EC ;

KONRAD, MW ;

CHILDS, A ;

WOLFE, SN ;

MIER, JW .

JOURNAL OF CLINICAL IMMUNOLOGY, 1986, 6 (06) :481-490

[2]

ARONSON F, 1988, IN PRESS J IMMUN

[3] PHASE-I EVALUATION OF RECOMBINANT INTERLEUKIN-2 IN PATIENTS WITH ADVANCED MALIGNANT DISEASE [J].

ATKINS, MB ;

GOULD, JA ;

ALLEGRETTA, M ;

LI, JJ ;

DEMPSEY, RA ;

RUDDERS, RA ;

PARKINSON, DR ;

REICHLIN, S ;

MIER, JW .

JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (09) :1380-1391

[4]

ATKINS MB, 1988, IN PRESS NEW ENGL J

[5]

AURON PE, 1987, J IMMUNOL, V138, P1447

[6] EFFECTS OF INTERLEUKIN-2 ON RENAL-FUNCTION IN PATIENTS RECEIVING IMMUNOTHERAPY FOR ADVANCED CANCER [J].

BELLDEGRUN, A ;

WEBB, DE ;

AUSTIN, HA ;

STEINBERG, SM ;

WHITE, DE ;

LINEHAN, WM ;

ROSENBERG, SA .

ANNALS OF INTERNAL MEDICINE, 1987, 106 (06) :817-822

[7] CONTROL OF CACHECTIN (TUMOR-NECROSIS-FACTOR) SYNTHESIS - MECHANISMS OF ENDOTOXIN RESISTANCE [J].

BEUTLER, B ;

KROCHIN, N ;

MILSARK, IW ;

LUEDKE, C ;

CERAMI, A .

SCIENCE, 1986, 232 (4753) :977-980

[8]

COHEN PJ, 1987, AM J PATHOL, V129, P208

[9]

COTRAN RS, 1988, J IMMUNOL, V140, P1883

[10]

DAMLE NK, 1987, J IMMUNOL, V138, P1779

← 1 2 3 4 5 6 7 →